Cannabis Investing: 3 Promising Strategies Ahead of Cannabis 2.0

There are a number of different strategies investors can use to invest in cannabis companies. One strategy is to buy the industry leaders such as Canopy Growth Corp (TSX:WEED)(NYSE:CGC).

| More on:
edit Powder of Cannabis (Drugs), Analysis of Cannabis in laboratory.

Image source: Getty Images

As an investor, allocating some of your portfolio to the cannabis sector is a prudent move. With cannabis 2.0 right around the corner, it’s critical for investors who have the risk tolerance to expose themselves to the sector to not miss out on any gains made.

This brings us to the ultimate questions: Which stock should you buy, and which strategy should you use?

There are three ways you can go about it. For starters, you could find the largest companies that are expected to dominate the industry.

Secondly, you can look for value, investing in a company that is clearly undervalued to its peers and wait for it to appreciate.

Lastly, you can find a growth company — one that is small today but has a ton of potential, especially when the edibles and extract market is legalized.


If you are looking for the largest company that is expected to dominate the industry, then look no further than Canopy Growth (TSX:WEED)(NYSE:CGC). For more than three years, Canopy has been growing itself, mainly through acquisitions.

It has recognized the power and ability of consolidation and has been making tons of strategic acquisitions. At first, the acquisitions helped to build its medical patients and growth capacity.

Soon, it began acquiring international companies as well as making strategic acquisitions to gain intellectual property.

Canopy today is focused on building its brands and building its global reach with medical cannabis. It sees global growth in medical cannabis as one of the top opportunities in the sector.

Its branding is still important too, and Canopy has done deals with a number of celebrities, such as Martha Stewart and Snoop Dogg, to help build its brand appeal among consumers.


Investors interested in finding an undervalued cannabis company should consider Village Farms International (TSX:VFF)(NASDAQ:VFF). Village Farms is one of the most undervalued cannabis stocks in Canada. In addition, it is also one of the only companies that has managed to turn a profit already.

Complementing its cannabis cultivation are Village Farms’s greenhouses, which are currently being used to grow vegetables.

In addition, these greenhouses, most of which are located in the U.S., act as a leg up on competition for when the U.S. gets around to legalizing cannabis federally. This is because Village Farms is in a unique position, where it can use its vegetable greenhouses as a turnkey cannabis cultivation facility, rather than having to build all new infrastructure.

Its roughly 33 times P/E ratio may seem like it isn’t that undervalued, but it’s priced for growth, just like all of its peers, which gives it a premium. Nonetheless, it’s still at an attractive valuation with a market cap of roughly $680 million.


For those investors looking for a growth company, one of the best companies with huge potential is Medipharm Labs (TSX:LABS). Medipharm is engaged in cannabis extraction, so the company is set to boom when edibles and extracts are legalized in October.

The edibles market is expected to grow to be a nearly $3 billion industry within the first five years. This is on top of the other cannabis spending that is forecasted and presents a major opportunity for investors.

Medipharm is one of the leading extraction and purification companies. It has built a wealth of proprietary methodologies and has been investing in its state-of-the-art technology.

It’s has also been ramping up its business model and product offerings, now having products for vaping, inputs for edibles, cannabis oils, soft gels, and extracts for pharmaceuticals.

It’s clear as the edible and extract market grows, Medipharm will directly benefit.

Currently, its market cap is around $630 million, which surely won’t last, as a company with this kind of potential will inevitably hit the $1 billion mark and will most likely surpass it.

Bottom line

Whether you choose to invest in the large companies, the ones with the most value, or in high-potential growth companies, the important thing is that you get your exposure and take advantage of the huge opportunity being offered ahead of the second wave of legalization.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Daniel Da Costa has no position in any of the stocks mentioned. The Motley Fool owns shares of Village Farms International, Inc. Village Farms is a recommendation of Hidden Gems Canada.

More on Cannabis Stocks

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

A close up image of Canadian $20 Dollar bills
Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »

Caution, careful
Cannabis Stocks

I Wouldn’t Touch This TSX Stock With a 60-Foot Pole

I wouldn't touch Canopy Growth Corp (TSX:WEED) stock with a 60-foot pole.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Why This Little-Known Cannabis Stock Could Double in 2024

This cannabis stock has already doubled this year since 52-week lows and could easily rise that much once more.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 420-Foot Pole

Down 87% from all-time highs, Cronos Group stock is a still a high-risk investment for long-term shareholders in 2024.

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth: Buy, Sell, or Hold?

Canopy Growth (TSX:WEED) stock should make a killing on U.S. expansion, but investors will need to be very patient.

Read more »

Marijuana plant and cannabis oil bottles isolated
Energy Stocks

3 Canadian Value Stocks to Buy Right Now

Undervalued Canadian stocks such as Secure Energy should be part of your shopping list in May 2024.

Read more »